Company news

BioAtla, Inc. news in 2022

BioAtla, Inc.'s news releases, calls and decks from 2022, newest first.

View company

BioAtla to Participate in the 41st Annual J.P. Morgan Healthcare Conference

December 21, 2022

BioAtla Announces $65 Million Underwritten Offering of its Common Stock

November 3, 2022

BioAtla Reports Third Quarter 2022 Financial Results and Highlights Recent Progress

November 2, 2022

BioAtla to Announce Third Quarter 2022 Financial Results and Provide Business Highlights on November 3, 2022

October 26, 2022

BioAtla Reports Second Quarter 2022 Financial Results And Highlights Recent Progress

August 8, 2022

BioAtla to Participate in the 2022 BTIG Biotechnology Conference

August 2, 2022

BioAtla to Announce Second Quarter 2022 Financial Results and Provide Business Highlights on August 9, 2022

August 1, 2022

BioAtla to Participate in 2022 Jefferies Global Healthcare Conference

May 31, 2022

BioAtla Reports First Quarter 2022 Financial Results and Highlights Recent Progress

May 3, 2022

BioAtla to Announce First Quarter 2022 Financial Results and Provide Business Highlights on May 4, 2022

April 7, 2022

BioAtla announces fourth quarter and full year 2021 financial results

February 28, 2022

BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin (BA3011) and Ozuriftamab Vedotin (BA3021) in Combination with Opdivo® (nivolumab) for Treatment of Solid Tumors

January 9, 2022

Calls in 2022

Decks in 2022